This page uses content from Wikipedia and is licensed under CC BY-SA.

Scutellarin

Scutellarin
7-(beta-D-Glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
Names
Other names
Breviscapine; Breviscapin; Scutellarein-7-glucuronide; Scutellarein-7beta-D-glucuronide; Scutellarein-7beta-D-glucuronoside; Scutellarein-7-O-beta-D-glucuronide; 7-(β-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
UNII
Properties
C21H18O12
Molar mass 462.36 g/mol
Hazards
Lethal dose or concentration (LD, LC):
1314 mg/kg (mouse, intravenous) [1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Scutellarin is a flavone, a type of phenolic chemical compound. It can be found in Scutellaria barbata and S. lateriflora. The determination of the structure of scutellarin took Guido Goldschmiedt many years: after the first publication on that topic in 1901, only in 1910 he managed to obtain enough starting material for more detailed studies.

Scutellarin is the focus of some very promising research and development for experimental medical therapies. This research will hopefully contribute to the development of new treatments for disease.

Scutellarin has been shown to induce apoptosis of ovarian and breast tumor cells in vitro. Scutellarin also shows protective effects for nerve cells that are affected by estrogen.[2]

Scutellarin has been shown as a potential treatment for diabetic retinopathy, which could prevent diabetic blindness. In laboratory studies, scutellarin inhibits hypoxia-induced and moderately high glucose-induced proliferation and vascular endothelial growth factor (VEGF) expression in human retinal endothelial cells (HRECs); thus, it could be a potential therapy for diabetic retinopathy. However, how scutellarin inhibits VEGF is unknown.[3]

Scutellarin has anti-HIV-1 effects as well. In laboratory studies, a drug-resistant type HIV-1 cell-to-cell infection was inhibited with significant potency. The scutellarin compound was found to inhibit several strains of HIV-1 replication with different potencies, by preventing HIV-1 particle attachment and cell fusion, as well as inhibiting HIV-1 retransmission.[4]

References

  1. ^ Zhongcaoyao (1983): Chinese Traditional and Herbal Medicine. Bd. 14, S. 33.
  2. ^ Zhu, Judy T. T.; Choi, Roy C. Y.; Chu, Glanice K. Y.; Cheung, Anna W. H.; Gao, Qiu T.; Li, Jun; Jiang, Zhi Y.; Dong, Tina T. X.; Tsim, Karl W. K. (2007-03-21). "Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death". Journal of Agricultural and Food Chemistry. 55 (6): 2438–2445. doi:10.1021/jf063299z. ISSN 0021-8561. PMID 17323972.
  3. ^ Wang, Difei; Wang, Lei; Gu, Jianqiu; Yang, Huijing; Liu, Nanqi; Lin, Yichen; Li, Xiaolin; Shao, Chen (September 2014). "Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway". Journal of Cardiovascular Pharmacology. 64 (3): 218–227. doi:10.1097/FJC.0000000000000109. ISSN 1533-4023. PMID 25192544.
  4. ^ Zhang, Gao-Hong; Wang, Qian; Chen, Ji-Jun; Zhang, Xue-Mei; Tam, Siu-Cheung; Zheng, Yong-Tang (2005-09-02). "The anti-HIV-1 effect of scutellarin". Biochemical and Biophysical Research Communications. 334 (3): 812–816. doi:10.1016/j.bbrc.2005.06.166. ISSN 0006-291X. PMID 16023998.